BioSpace News Archive

Bio-Techne Corporation (NASDAQ: TECH) today announced that management will host a conference call and webcast on Tuesday, November 2, 2021 , at 8:00 a.m. CDT to review first quarter 2022 financial results.

Cellares Corporation, today announced the appointment of John Tomtishen as Vice President of Operations.

Peer-reviewed study in stage III colorectal cancer demonstrates the prognostic value of ctDNA growth rate as measured by Signatera in over 1200 plasma samples

Allergan Aesthetics, an AbbVie company (NYSE: ABBV), is continuing its commitment to breast health, awareness, restoration, and research in support of breast cancer awareness month.

The Twist Alliance Pan-Cancer Methylation Panel was launched globally on September 24th (US time).

AcureX Therapeutics Corporation today announced that it was selected to present at the Oppenheimer Biotechnology – Emerging Science Summit on October 15th, 2021.

Repertoire Immune Medicines announced today that the first patient has been dosed in the company’s Phase 1 study of RPTR-168 (PRIME IL-12)

Movair today announced the U.S. commercial launch of Luisa, an advanced ventilator intended for use in homes, institutions, hospitals or portable applications for both invasive and non-invasive ventilation.

PsyBio Therapeutics Corp. today announced that Evan Levine , CEO and Chairman of PsyBio, will present at the KCSA Psychedelics Investor Conference to be held at VirtualInvestorConferences.com on Thursday, October 14th at 10:30 a.m. ET.

Organon (NYSE: OGN), a global women’s health company, today announced clearance by the U.S. Food and Drug Administration (FDA) of the Special 510(k) for technological updates to the Jada® System, intended to provide control and treatment of abnormal postpartum uterine bleeding or hemorrhage when conservative management is warranted.